167 related articles for article (PubMed ID: 15338883)
1. [Selective tumor-accumulation of HPMA copolymer-mitoxantrone conjugates].
Huang Y; Zhang ZR
Yao Xue Xue Bao; 2004 May; 39(5):374-9. PubMed ID: 15338883
[TBL] [Abstract][Full Text] [Related]
2. [Biodistribution of N-(2-hydroxypropyl) methacrylamide copolymer-bound mitoxantrone in mice bearing Ehrlich solid tumor].
Huang Y; Zhang Z; Liu W
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2004 Dec; 21(6):930-4. PubMed ID: 15646335
[TBL] [Abstract][Full Text] [Related]
3. N-(2-hydroxypropyl)methacrylamide copolymer-6-(3-aminopropyl)-ellipticine conjugates. Synthesis, in vitro, and preliminary in vivo evaluation.
Searle F; Gac-Breton S; Keane R; Dimitrijevic S; Brocchini S; Sausville EA; Duncan R
Bioconjug Chem; 2001; 12(5):711-8. PubMed ID: 11562189
[TBL] [Abstract][Full Text] [Related]
4. Two step mechanisms of tumor selective delivery of N-(2-hydroxypropyl)methacrylamide copolymer conjugated with pirarubicin via an acid-cleavable linkage.
Nakamura H; Etrych T; Chytil P; Ohkubo M; Fang J; Ulbrich K; Maeda H
J Control Release; 2014 Jan; 174():81-7. PubMed ID: 24269967
[TBL] [Abstract][Full Text] [Related]
5. HPMA copolymer-cyclic RGD conjugates for tumor targeting.
Pike DB; Ghandehari H
Adv Drug Deliv Rev; 2010 Feb; 62(2):167-83. PubMed ID: 19951733
[TBL] [Abstract][Full Text] [Related]
6. Antitumor activity of N-(2-hydroxypropyl) methacrylamide copolymer-Mesochlorine e6 and adriamycin conjugates in combination treatments.
Shiah JG; Sun Y; Peterson CM; Straight RC; Kopecek J
Clin Cancer Res; 2000 Mar; 6(3):1008-15. PubMed ID: 10741728
[TBL] [Abstract][Full Text] [Related]
7. Highly effective anti-tumor nanomedicines based on HPMA copolymer conjugates with pirarubicin prepared by controlled RAFT polymerization.
Randárová E; Nakamura H; Islam R; Studenovský M; Mamoru H; Fang J; Chytil P; Etrych T
Acta Biomater; 2020 Apr; 106():256-266. PubMed ID: 32058082
[TBL] [Abstract][Full Text] [Related]
8. Tumor-targeted HPMA copolymer-(RGDfK)-(CHX-A''-DTPA) conjugates show increased kidney accumulation.
Borgman MP; Coleman T; Kolhatkar RB; Geyser-Stoops S; Line BR; Ghandehari H
J Control Release; 2008 Dec; 132(3):193-9. PubMed ID: 18687371
[TBL] [Abstract][Full Text] [Related]
9. The structure-dependent toxicity, pharmacokinetics and anti-tumour activity of HPMA copolymer conjugates in the treatment of solid tumours and leukaemia.
Tomalova B; Sirova M; Rossmann P; Pola R; Strohalm J; Chytil P; Cerny V; Tomala J; Kabesova M; Rihova B; Ulbrich K; Etrych T; Kovar M
J Control Release; 2016 Feb; 223():1-10. PubMed ID: 26708020
[TBL] [Abstract][Full Text] [Related]
10. Passive and active hepatoma tumor targeting of new N-(2-hydroxypropyl)methacrylamide copolymer conjugates: synthesis, characterization, and evaluation in vitro and in vivo.
Yuan J; Yuan B; Guo H; Zeng X; Wang X; Liao S; Li J; Jia Z; Song F; Wang F
J Biomater Sci Polym Ed; 2013; 24(12):1472-83. PubMed ID: 23829459
[TBL] [Abstract][Full Text] [Related]
11. [In vitro release study, in vivo evaluation of biodistribution and antitumor activity of HPMA copolymer-5-fluorouracil conjugates].
Yuan F; Zhang ZR; Yang YX; Huang Y
Yao Xue Xue Bao; 2008 Nov; 43(11):1152-6. PubMed ID: 19239037
[TBL] [Abstract][Full Text] [Related]
12. Molecular imaging of HPMA copolymers: visualizing drug delivery in cell, mouse and man.
Lu ZR
Adv Drug Deliv Rev; 2010 Feb; 62(2):246-57. PubMed ID: 20060431
[TBL] [Abstract][Full Text] [Related]
13. Targeting tumor angiogenic vasculature using polymer-RGD conjugates.
Mitra A; Mulholland J; Nan A; McNeill E; Ghandehari H; Line BR
J Control Release; 2005 Jan; 102(1):191-201. PubMed ID: 15653145
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and characterization of the tumor targeting mitoxantrone-insulin conjugate.
Liu WS; Huang Y; Zhang ZR
Arch Pharm Res; 2003 Nov; 26(11):892-7. PubMed ID: 14661852
[TBL] [Abstract][Full Text] [Related]
15. Biodistribution of HPMA copolymer-aminohexylgeldanamycin-RGDfK conjugates for prostate cancer drug delivery.
Borgman MP; Aras O; Geyser-Stoops S; Sausville EA; Ghandehari H
Mol Pharm; 2009; 6(6):1836-47. PubMed ID: 19743884
[TBL] [Abstract][Full Text] [Related]
16. Conjugates of doxorubicin with graft HPMA copolymers for passive tumor targeting.
Etrych T; Chytil P; Mrkvan T; Sírová M; Ríhová B; Ulbrich K
J Control Release; 2008 Dec; 132(3):184-92. PubMed ID: 18534705
[TBL] [Abstract][Full Text] [Related]
17. Biodistribution of free and N-(2-hydroxypropyl)methacrylamide copolymer-bound mesochlorin e(6) and adriamycin in nude mice bearing human ovarian carcinoma OVCAR-3 xenografts.
Shiah JJ; Sun Y; Peterson CM; Kopecek J
J Control Release; 1999 Aug; 61(1-2):145-57. PubMed ID: 10469911
[TBL] [Abstract][Full Text] [Related]
18. Development of HPMA copolymer-anticancer conjugates: clinical experience and lessons learnt.
Duncan R
Adv Drug Deliv Rev; 2009 Nov; 61(13):1131-48. PubMed ID: 19699249
[TBL] [Abstract][Full Text] [Related]
19. Biodistribution and pharmacokinetics of colon-specific HPMA copolymer--9-aminocamptothecin conjugate in mice.
Gao SQ; Lu ZR; Kopecková P; Kopecek J
J Control Release; 2007 Feb; 117(2):179-85. PubMed ID: 17150276
[TBL] [Abstract][Full Text] [Related]
20. HPMA copolymer-1,5-diazaanthraquinone conjugates as novel anticancer therapeutics.
Vicent MJ; Manzanaro S; de la Fuente JA; Duncan R
J Drug Target; 2004; 12(8):503-15. PubMed ID: 15621676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
